We obtained mRNA data from patients receiving radiotherapy in the GEO database for validation and found that CRC patients with lower ZNF281 expression had better survival outcomes, which was consistent with our results (Figure 1G and H). The gene discussed is ZNF281; the disease is colorectal carcinoma.